Ambev (ABEV) Research & Development (2012 - 2026)

Ambev (ABEV) has reported Research & Development for 15 consecutive years, with -$461.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 20.22% year-over-year to -$461.4 million; the trailing twelve-month figure through Jun 2026 stood at -$1.6 billion (down 4.22% YoY), and the FY2025 full-year result was -$405.3 million, up 72.72% from the prior year.
• Research & Development retreated to -$461.4 million in Q2 2026 per ABEV's latest filing, from -$380.4 million in the prior quarter.
• Across five years, Research & Development topped out at -$175864.9 in Q1 2023 and bottomed at -$461.4 million in Q2 2026.
• Historically, Research & Development has averaged -$362.0 million across 5 years, with a median of -$380.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Research & Development soared 99.94% in 2023, then plunged 216600.25% in 2024.
• Over 5 years, Research & Development stood at -$389.3 million in 2022, then increased by 6.4% to -$364.4 million in 2023, then decreased by 18.55% to -$432.0 million in 2024, then gained by 6.17% to -$405.3 million in 2025, then decreased by 13.84% to -$461.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered -$461.4 million, -$380.4 million, and -$405.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.